2’S-α-Fluoro tribenzoyl sofosbuvir intermidiate
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

2’S-α-Fluoro tribenzoyl sofosbuvir intermidiate

● In Stock

Catalogue No.:VE009111
CAS No.:N/A
Mol. Formula:C31H26FN3O7
Mol. Weight:571.55 g/mol

Additional information on 2’S-α-Fluoro tribenzoyl sofosbuvir intermidiate

Parent drug

Sofosbuvir

IUPAC Name

(2R, 3R, 4S, 5S)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate

Synonyms

N/A

Description

2’S-α-Fluoro tribenzoyl sofosbuvir intermidiate is an impurity present in sofosbuvir, Sofosbuvir is metabolized into its active form as the antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-triphosphate, which is used in combination therapy with other antiviral medications to treat chronic hepatitis C virus (HCV) infected patients with HCV genotypes 1-6, and to treat HCV and HIV, co-infected patients.

References

Bhatia, H. K., Singh, H., Grewal, N., & Natt, N. K. (2014). Sofosbuvir: A novel treatment option for chronic hepatitis C infection. Journal of Pharmacology and Pharmacotherapeutics, 5(4), 278–284. https://doi.org/10.4103/0976-500x.142464

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url